Initiative
The Site Voice in Clinical Trial Reform
The major clinical trial policy reforms shaping the next era of U.S. drug development are being written without sites in the room. These are the same organizations that enroll patients, execute protocols, and absorb the operational consequences when a policy is designed without their input. SCRS closes that gap, putting 12,000+ sites’ operational experience and data directly in front of FDA, Congress, and the institutions shaping the next generation of U.S. clinical development, so reform is built on how trials actually run, not just how they’re intended to run on paper.
Closing the Gap Between Policy and Practice
Federal clinical trial policy is being redesigned around sponsors, CROs, academic medical centers, and health systems, not the sites that actually enroll and treat patients. That absence isn’t a technicality; it’s why these same policies keep producing the problems they’re meant to solve. Protocols built without site input lead to amendments and enrollment shortfalls. SCRS closes this gap by bringing site-level data into policy development before it‘s finalized, so reform is executable in practice, not just sound on paper.
Program Goals
Supporting Organizations
Key Milestones
Site Success Impacts Everyone In Research
Be a part of the impact.